The School of Life Course & Population Sciences is one of six Schools that make up the Faculty of Life Sciences & Medicine at King’s College London. The School unites over 400 experts in women and children’s health, nutritional sciences, population health and the molecular genetics of human disease. Our research links the causes of common health problems to life’s landmark stages, treating life, disease and healthcare as a continuum. We are interdisciplinary by nature and this innovative approach works: 91 per cent of our research submitted to the Subjects Allied to Medicine (Pharmacy, Nutritional Sciences and Women’s Health cluster) for REF was rated as world-leading or internationally excellent. We use this expertise to teach the next generation of health professionals and research scientists. Based across King’s Denmark Hill, Guy’s, St Thomas’ and Waterloo campuses, our academic programme of teaching, research and clinical practice is embedded across five Departments.  

 

The Santos Lab is a clinical translational research group comprising clinicians and scientists at various career stages.

 

Our research focuses on food allergy, improving the diagnosis of food allergy and advancing our understanding of the immune mechanisms underlying food allergy and oral tolerance to identify new targets for prevention and treatment.

 

We are a friendly, enthusiastic, supportive and inclusive team that thrives on collaboration across disciplines. We are proud of our positive research culture and our shared commitment to delivering research that makes a meaningful difference to patients and families. The group is part of the Faculty of Life Sciences & Medicine at King’s College London, based in central London, with laboratories on Guy’s Campus and clinical space on St Thomas’ Hospital, with close links to Evelina London Children’s Hospital.

We are seeking an organised, proactive and highly motivated Project Manager and Patient & Public Involvement and Engagement (PPIE) Liaison to join the PRIME Study (Peanut Response and Immunity in Early-life), a major Medical Research Council (MRC)-funded research programme based at King’s College London and Evelina London Children’s Hospital. The PRIME study aims to understand the immune mechanisms underlying oral tolerance to peanut and the development of peanut allergy in early childhood, with the ultimate goal of identifying pathways that may lead to curative treatments for food allergy.

 

Food allergy affects approximately 8% of children and can have a major impact on quality of life for children and their families. While early introduction of peanut in infancy dramatically reduces the risk of peanut allergy, the biological mechanisms responsible for this protective effect are not well understood. PRIME combines clinical research, advanced immunology, systems biology and innovative human gut organoid models to address this important scientific and clinical challenge.

The successful candidate will play a central role in the delivery of this ambitious programme, working closely with the Chief Investigator, principal investigators, research scientists, clinical teams, data managers, patients, families and external collaborators. The postholder will coordinate all aspects of study delivery, including recruitment, study visits, governance activities, ethics and regulatory submissions, reporting, stakeholder engagement and participant communications. They will help ensure that the study is delivered efficiently, to the highest standards of scientific integrity and regulatory compliance.

 

A key component of the role will be leading Patient and Public Involvement and Engagement (PPIE) activities across the programme. The postholder will work closely with children, parents, carers, patient organisations and community stakeholders to ensure that the experiences and priorities of families affected by food allergy are embedded throughout study delivery, dissemination and future research development. There will also be opportunities, if desired, to develop supervised research activities embedded within the role.

 

This is an exciting opportunity to contribute to a high-profile translational research programme with the potential to transform our understanding and treatment of food allergy.

 

This is a part time post (28 hours per week) and you will be offered a fixed-term contract until 30 April 2029, starting on the 1 November 2026. The role will be based at St Thomas’ Hospital, with close links to Guy’s Campus and Evelina London Children’s Hospital.